The Journal of allergy and clinical immunology. 2017 May 16. pii: S0091-6749(17)30758-3. doi: 10.1016/j.jaci.2017.04.034
|
AllergoOncology: IgE- and IgG4- mediated immune mechanisms linking Allergy with Cancer and their translational implications.
|
Jensen-Jarolim E1, Turner MC2, Karagiannis SN3 |
 Author information
1Inst. of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna; The Interuniversity Messerli Research Institute, Univ. of Veterinary Medicine Vienna, Medical University Vienna, University Vienna, Austria. Electronic address: erika.jensen-Jarolim@meduniwien.ac.at.
2Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada.
3St. John's Institute of Dermatology; Division of Genetics & Molecular Medicine; Faculty of Life Sciences and Medicine; King's College London; NIHR Biomedical Research Centre at Guy's and St. Thomas' Hospitals and King's College London; Guy's Hospital; King's College London; London, UK.
|
KEYWORDS: ADCC, AllergoOncology, Allergy, IgE, cancer, clinical oncology, effector cells, oncoimmunology, tolerance, tumor
|
Publikations ID: 28526623
Quelle: öffnen
|